Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum The Medipattern Corporation V.MKI

TSXV:MKI - Post Discussion

The Medipattern Corporation > Sprott/Charus isnt done, obviousssly
View:
Post by BigClown on Feb 03, 2012 10:09am

Sprott/Charus isnt done, obviousssly

Like I said they are a bit more than half done but with the recent volumn, it may take longer than they antiacipated....unlesss they decid they just want OUT....then its gonna be TIMBERRRRR!
Comment by RE38 on Feb 03, 2012 11:07am
If Clarus worked for sprott then they ARE done. They sold about 2.5M shares and that's what Sprott had left. Also that's not indicative of what people really think of MKI. Apparently the analyst that covered MKI left Sprott so they sold indiscriminately. That will be a decision they will come to regret.   All this talk of EKG....MKI has the same market, except marketed to hospitals ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities